Experienced in Temporal Arteritis

Isabelle Durieu

Lyon, FR 
Experienced in Temporal Arteritis
Lyon, FR 
OverviewLocationsClinical Research

Overview

Isabelle Durieu practices in Lyon, France. Ms. Durieu is rated as an Experienced expert by MediFind in the treatment of Temporal Arteritis. Her top areas of expertise are Cystic Fibrosis, Mast Cell Activation Syndrome (MCAS), Systemic Mastocytosis, Lung Transplant, and Splenectomy.

Her clinical research consists of co-authoring 191 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Temporal Arteritis.

Gender
Female

Locations

Lyon, France
Other Locations
Pierre-la-treiche, 69495, France
Villeurbanne, 69100, France
Oullins, France
Paris, France
Saint-genis-les-ollieres, France
Saint-claude-de-diray, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)
Outcome of Acquired Haemophilia With Steroid Combined With Cyclophosphamide Versus Steroid Combined With Rituximab (CREHA Study)
Enrollment Status: Completed
Publish Date: October 06, 2025
Intervention Type: Drug
Study Drugs: Steroid, Cyclophosphamide, Rituximab
Study Phase: Phase 3
Observational Study of Glucose Tolerance Abnormalities in Patient With Cystic Fibrosis Homozygous for Phe 508 Del CFTR Treated by Lumacaftor-Ivacaftor
Observational Study of Glucose Tolerance Abnormalities in Patient With Cystic Fibrosis Homozygous for Phe 508 Del CFTR Treated by Lumacaftor-Ivacaftor
Enrollment Status: Completed
Publish Date: November 24, 2021
Intervention Type: Drug
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection
Enrollment Status: Terminated
Publish Date: October 26, 2020
Intervention Type: Other, Drug
Study Phase: Phase 2
SAFETIM Besoins: Suivi Des Adolescents Des Familles et Des Equipes Pour Une Transition Idéale en Mucoviscidose Etude Des Besoins Adolescents et Parent Avant après Transition
SAFETIM Besoins: Suivi Des Adolescents Des Familles et Des Equipes Pour Une Transition Idéale en Mucoviscidose Etude Des Besoins Adolescents et Parent Avant après Transition
Enrollment Status: Completed
Publish Date: March 30, 2020
Intervention Type: Other
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of CTX-4430 Administered Orally Once-Daily for 48 Weeks in Adult Patients With Cystic Fibrosis
Enrollment Status: Completed
Publish Date: September 04, 2019
Intervention Type: Drug
Study Phase: Phase 2
SALTO -2 ( Long Term Monitoring In Oncology ) : Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes, Multicentric Study
SALTO -2 ( Long Term Monitoring In Oncology ) : Getting Long-term Management of Adult Children Cured of Childhood Cancer in Rhône-Alpes, Multicentric Study
Enrollment Status: Completed
Publish Date: October 22, 2018
Intervention Type: Other
View 5 Less Clinical Trials

189 Total Publications

Severe anemia in a 44-year-old woman
Severe anemia in a 44-year-old woman
Journal: La Revue de medecine interne
Published: August 14, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Durieu's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 57 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile